Global Paclitaxel Drug-Eluting Balloon Market Growth 2025-2031

Report ID: 3015584 | Published Date: Mar 2026 | No. of Page: 106 | Base Year: 2025 | Rating: 3.9 | Webstory: Check our Web story

Impact of U.S Tarrifs Analyzed 2025

1 Scope of the Report
 1.1 Market Introduction
 1.2 Years Considered
 1.3 Research Objectives
 1.4 Market Research Methodology
 1.5 Research Process and Data Source
 1.6 Economic Indicators
 1.7 Currency Considered
 1.8 Market Estimation Caveats
2 Executive Summary
 2.1 World Market Overview
 2.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales 2020-2031
 2.1.2 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Geographic Region, 2020, 2024 & 2031
 2.1.3 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Country/Region, 2020, 2024 & 2031
 2.2 Paclitaxel Drug-Eluting Balloon Segment by Type
 2.2.1 Balloon-Only Coating
 2.2.2 Drug-Coated Balloon
 2.3 Paclitaxel Drug-Eluting Balloon Sales by Type
 2.3.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2020-2025)
 2.3.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Type (2020-2025)
 2.3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2020-2025)
 2.4 Paclitaxel Drug-Eluting Balloon Segment by Application
 2.4.1 Peripheral Artery Disease
 2.4.2 Coronary Artery Disease
 2.5 Paclitaxel Drug-Eluting Balloon Sales by Application
 2.5.1 Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2020-2025)
 2.5.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Application (2020-2025)
 2.5.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2020-2025) 
3 Global by Company
 3.1 Global Paclitaxel Drug-Eluting Balloon Breakdown Data by Company
 3.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Company (2020-2025)
 3.1.2 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2020-2025)
 3.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Company (2020-2025)
 3.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2020-2025)
 3.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2020-2025)
 3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Company
 3.4 Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution, Sales Area, Product Type
 3.4.1 Key Manufacturers Paclitaxel Drug-Eluting Balloon Product Location Distribution
 3.4.2 Players Paclitaxel Drug-Eluting Balloon Products Offered
 3.5 Market Concentration Rate Analysis
 3.5.1 Competition Landscape Analysis
 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 3.6 New Products and Potential Entrants
 3.7 Market M&A Activity & Strategy
4 World Historic Review for Paclitaxel Drug-Eluting Balloon by Geographic Region
 4.1 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Geographic Region (2020-2025)
 4.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Geographic Region (2020-2025)
 4.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Geographic Region (2020-2025)
 4.2 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Country/Region (2020-2025)
 4.2.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Country/Region (2020-2025)
 4.2.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Country/Region (2020-2025)
 4.3 Americas Paclitaxel Drug-Eluting Balloon Sales Growth
 4.4 APAC Paclitaxel Drug-Eluting Balloon Sales Growth
 4.5 Europe Paclitaxel Drug-Eluting Balloon Sales Growth
 4.6 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Growth
5 Americas
 5.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country
 5.1.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025)
 5.1.2 Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2025)
 5.2 Americas Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025)
 5.3 Americas Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2025)
 5.4 United States
 5.5 Canada
 5.6 Mexico
 5.7 Brazil
6 APAC
 6.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region
 6.1.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2020-2025)
 6.1.2 APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2020-2025)
 6.2 APAC Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025)
 6.3 APAC Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2025)
 6.4 China
 6.5 Japan
 6.6 South Korea
 6.7 Southeast Asia
 6.8 India
 6.9 Australia
 6.10 China Taiwan
7 Europe
 7.1 Europe Paclitaxel Drug-Eluting Balloon by Country
 7.1.1 Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025)
 7.1.2 Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2025)
 7.2 Europe Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025)
 7.3 Europe Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2025)
 7.4 Germany
 7.5 France
 7.6 UK
 7.7 Italy
 7.8 Russia
8 Middle East & Africa
 8.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon by Country
 8.1.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025)
 8.1.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2025)
 8.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025)
 8.3 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2025)
 8.4 Egypt
 8.5 South Africa
 8.6 Israel
 8.7 Turkey
 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
 9.1 Market Drivers & Growth Opportunities
 9.2 Market Challenges & Risks
 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
 10.1 Raw Material and Suppliers
 10.2 Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon
 10.3 Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
 10.4 Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
11 Marketing, Distributors and Customer
 11.1 Sales Channel
 11.1.1 Direct Channels
 11.1.2 Indirect Channels
 11.2 Paclitaxel Drug-Eluting Balloon Distributors
 11.3 Paclitaxel Drug-Eluting Balloon Customer
12 World Forecast Review for Paclitaxel Drug-Eluting Balloon by Geographic Region
 12.1 Global Paclitaxel Drug-Eluting Balloon Market Size Forecast by Region
 12.1.1 Global Paclitaxel Drug-Eluting Balloon Forecast by Region (2026-2031)
 12.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Region (2026-2031)
 12.2 Americas Forecast by Country (2026-2031)
 12.3 APAC Forecast by Region (2026-2031)
 12.4 Europe Forecast by Country (2026-2031)
 12.5 Middle East & Africa Forecast by Country (2026-2031)
 12.6 Global Paclitaxel Drug-Eluting Balloon Forecast by Type (2026-2031)
 12.7 Global Paclitaxel Drug-Eluting Balloon Forecast by Application (2026-2031)
13 Key Players Analysis
 13.1 Medtronic
 13.1.1 Medtronic Company Information
 13.1.2 Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.1.3 Medtronic Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.1.4 Medtronic Main Business Overview
 13.1.5 Medtronic Latest Developments
 13.2 Boston Scientific
 13.2.1 Boston Scientific Company Information
 13.2.2 Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.2.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.2.4 Boston Scientific Main Business Overview
 13.2.5 Boston Scientific Latest Developments
 13.3 B. Braun
 13.3.1 B. Braun Company Information
 13.3.2 B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.3.3 B. Braun Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.3.4 B. Braun Main Business Overview
 13.3.5 B. Braun Latest Developments
 13.4 Cook Medical
 13.4.1 Cook Medical Company Information
 13.4.2 Cook Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.4.3 Cook Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.4.4 Cook Medical Main Business Overview
 13.4.5 Cook Medical Latest Developments
 13.5 Cardionovum
 13.5.1 Cardionovum Company Information
 13.5.2 Cardionovum Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.5.3 Cardionovum Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.5.4 Cardionovum Main Business Overview
 13.5.5 Cardionovum Latest Developments
 13.6 Aachen Resonance
 13.6.1 Aachen Resonance Company Information
 13.6.2 Aachen Resonance Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.6.3 Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.6.4 Aachen Resonance Main Business Overview
 13.6.5 Aachen Resonance Latest Developments
 13.7 QT Vascular
 13.7.1 QT Vascular Company Information
 13.7.2 QT Vascular Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.7.3 QT Vascular Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.7.4 QT Vascular Main Business Overview
 13.7.5 QT Vascular Latest Developments
 13.8 Biotronic
 13.8.1 Biotronic Company Information
 13.8.2 Biotronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.8.3 Biotronic Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.8.4 Biotronic Main Business Overview
 13.8.5 Biotronic Latest Developments
 13.9 Philips
 13.9.1 Philips Company Information
 13.9.2 Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.9.3 Philips Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.9.4 Philips Main Business Overview
 13.9.5 Philips Latest Developments
 13.10 Eurocor
 13.10.1 Eurocor Company Information
 13.10.2 Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.10.3 Eurocor Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.10.4 Eurocor Main Business Overview
 13.10.5 Eurocor Latest Developments
 13.11 Yinyi Biotech
 13.11.1 Yinyi Biotech Company Information
 13.11.2 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.11.3 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.11.4 Yinyi Biotech Main Business Overview
 13.11.5 Yinyi Biotech Latest Developments
 13.12 Lepu Medical Technology
 13.12.1 Lepu Medical Technology Company Information
 13.12.2 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 13.12.3 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2020-2025)
 13.12.4 Lepu Medical Technology Main Business Overview
 13.12.5 Lepu Medical Technology Latest Developments
14 Research Findings and Conclusion
List of Tables
 Table 1. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Balloon-Only Coating
 Table 4. Major Players of Drug-Coated Balloon
 Table 5. Global Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025) & (K Units)
 Table 6. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2020-2025)
 Table 7. Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2020-2025) & ($ million)
 Table 8. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2020-2025)
 Table 9. Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2020-2025) & (US$/Unit)
 Table 10. Global Paclitaxel Drug-Eluting Balloon Sale by Application (2020-2025) & (K Units)
 Table 11. Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2020-2025)
 Table 12. Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2020-2025)
 Table 14. Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2020-2025) & (US$/Unit)
 Table 15. Global Paclitaxel Drug-Eluting Balloon Sales by Company (2020-2025) & (K Units)
 Table 16. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2020-2025)
 Table 17. Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2020-2025)
 Table 19. Global Paclitaxel Drug-Eluting Balloon Sale Price by Company (2020-2025) & (US$/Unit)
 Table 20. Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution and Sales Area
 Table 21. Players Paclitaxel Drug-Eluting Balloon Products Offered
 Table 22. Paclitaxel Drug-Eluting Balloon Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Paclitaxel Drug-Eluting Balloon Sales by Geographic Region (2020-2025) & (K Units)
 Table 26. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Paclitaxel Drug-Eluting Balloon Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Paclitaxel Drug-Eluting Balloon Sales by Country/Region (2020-2025) & (K Units)
 Table 30. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Paclitaxel Drug-Eluting Balloon Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025) & (K Units)
 Table 34. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2020-2025)
 Table 35. Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025) & (K Units)
 Table 37. Americas Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2025) & (K Units)
 Table 38. APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2020-2025) & (K Units)
 Table 39. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2020-2025)
 Table 40. APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025) & (K Units)
 Table 42. APAC Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2025) & (K Units)
 Table 43. Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025) & (K Units)
 Table 44. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025) & (K Units)
 Table 46. Europe Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2025) & (K Units)
 Table 47. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025) & (K Units)
 Table 48. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025) & (K Units)
 Table 50. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2025) & (K Units)
 Table 51. Key Market Drivers & Growth Opportunities of Paclitaxel Drug-Eluting Balloon
 Table 52. Key Market Challenges & Risks of Paclitaxel Drug-Eluting Balloon
 Table 53. Key Industry Trends of Paclitaxel Drug-Eluting Balloon
 Table 54. Paclitaxel Drug-Eluting Balloon Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Paclitaxel Drug-Eluting Balloon Distributors List
 Table 57. Paclitaxel Drug-Eluting Balloon Customer List
 Table 58. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2026-2031) & (K Units)
 Table 59. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2026-2031) & (K Units)
 Table 61. Americas Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2026-2031) & (K Units)
 Table 63. APAC Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2026-2031) & (K Units)
 Table 65. Europe Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2026-2031) & (K Units)
 Table 67. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Type (2026-2031) & (K Units)
 Table 69. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Application (2026-2031) & (K Units)
 Table 71. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. Medtronic Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 73. Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 74. Medtronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Medtronic Main Business
 Table 76. Medtronic Latest Developments
 Table 77. Boston Scientific Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 78. Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 79. Boston Scientific Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Boston Scientific Main Business
 Table 81. Boston Scientific Latest Developments
 Table 82. B. Braun Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 83. B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 84. B. Braun Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. B. Braun Main Business
 Table 86. B. Braun Latest Developments
 Table 87. Cook Medical Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 88. Cook Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 89. Cook Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Cook Medical Main Business
 Table 91. Cook Medical Latest Developments
 Table 92. Cardionovum Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 93. Cardionovum Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 94. Cardionovum Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Cardionovum Main Business
 Table 96. Cardionovum Latest Developments
 Table 97. Aachen Resonance Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 98. Aachen Resonance Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 99. Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Aachen Resonance Main Business
 Table 101. Aachen Resonance Latest Developments
 Table 102. QT Vascular Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 103. QT Vascular Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 104. QT Vascular Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. QT Vascular Main Business
 Table 106. QT Vascular Latest Developments
 Table 107. Biotronic Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 108. Biotronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 109. Biotronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 110. Biotronic Main Business
 Table 111. Biotronic Latest Developments
 Table 112. Philips Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 113. Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 114. Philips Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 115. Philips Main Business
 Table 116. Philips Latest Developments
 Table 117. Eurocor Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 118. Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 119. Eurocor Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 120. Eurocor Main Business
 Table 121. Eurocor Latest Developments
 Table 122. Yinyi Biotech Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 123. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 124. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 125. Yinyi Biotech Main Business
 Table 126. Yinyi Biotech Latest Developments
 Table 127. Lepu Medical Technology Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
 Table 128. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
 Table 129. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 130. Lepu Medical Technology Main Business
 Table 131. Lepu Medical Technology Latest Developments


List of Figures
 Figure 1. Picture of Paclitaxel Drug-Eluting Balloon
 Figure 2. Paclitaxel Drug-Eluting Balloon Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Paclitaxel Drug-Eluting Balloon Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Paclitaxel Drug-Eluting Balloon Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Paclitaxel Drug-Eluting Balloon Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2024)
 Figure 10. Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Balloon-Only Coating
 Figure 12. Product Picture of Drug-Coated Balloon
 Figure 13. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type in 2025
 Figure 14. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2020-2025)
 Figure 15. Paclitaxel Drug-Eluting Balloon Consumed in Peripheral Artery Disease
 Figure 16. Global Paclitaxel Drug-Eluting Balloon Market: Peripheral Artery Disease (2020-2025) & (K Units)
 Figure 17. Paclitaxel Drug-Eluting Balloon Consumed in Coronary Artery Disease
 Figure 18. Global Paclitaxel Drug-Eluting Balloon Market: Coronary Artery Disease (2020-2025) & (K Units)
 Figure 19. Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2024)
 Figure 20. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application in 2025
 Figure 21. Paclitaxel Drug-Eluting Balloon Sales by Company in 2025 (K Units)
 Figure 22. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company in 2025
 Figure 23. Paclitaxel Drug-Eluting Balloon Revenue by Company in 2025 ($ millions)
 Figure 24. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company in 2025
 Figure 25. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Geographic Region (2020-2025)
 Figure 26. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region in 2025
 Figure 27. Americas Paclitaxel Drug-Eluting Balloon Sales 2020-2025 (K Units)
 Figure 28. Americas Paclitaxel Drug-Eluting Balloon Revenue 2020-2025 ($ millions)
 Figure 29. APAC Paclitaxel Drug-Eluting Balloon Sales 2020-2025 (K Units)
 Figure 30. APAC Paclitaxel Drug-Eluting Balloon Revenue 2020-2025 ($ millions)
 Figure 31. Europe Paclitaxel Drug-Eluting Balloon Sales 2020-2025 (K Units)
 Figure 32. Europe Paclitaxel Drug-Eluting Balloon Revenue 2020-2025 ($ millions)
 Figure 33. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales 2020-2025 (K Units)
 Figure 34. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue 2020-2025 ($ millions)
 Figure 35. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2025
 Figure 36. Americas Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2020-2025)
 Figure 37. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2020-2025)
 Figure 38. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2020-2025)
 Figure 39. United States Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 40. Canada Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 41. Mexico Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 42. Brazil Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 43. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region in 2025
 Figure 44. APAC Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2020-2025)
 Figure 45. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2020-2025)
 Figure 46. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2020-2025)
 Figure 47. China Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 48. Japan Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 49. South Korea Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 50. Southeast Asia Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 51. India Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 52. Australia Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 53. China Taiwan Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 54. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2025
 Figure 55. Europe Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2020-2025)
 Figure 56. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2020-2025)
 Figure 57. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2020-2025)
 Figure 58. Germany Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 59. France Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 60. UK Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 61. Italy Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 62. Russia Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 63. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2020-2025)
 Figure 64. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2020-2025)
 Figure 65. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2020-2025)
 Figure 66. Egypt Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 67. South Africa Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 68. Israel Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 69. Turkey Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 70. GCC Countries Paclitaxel Drug-Eluting Balloon Revenue Growth 2020-2025 ($ millions)
 Figure 71. Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon in 2025
 Figure 72. Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
 Figure 73. Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
 Figure 74. Channels of Distribution
 Figure 75. Global Paclitaxel Drug-Eluting Balloon Sales Market Forecast by Region (2026-2031)
 Figure 76. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Region (2026-2031)
 Figure 77. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Type (2026-2031)
 Figure 78. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Type (2026-2031)
 Figure 79. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Application (2026-2031)
 Figure 80. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Application (2026-2031)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Medtronic|||Boston Scientific|||B. Braun|||Cook Medical|||Cardionovum|||Aachen Resonance|||QT Vascular|||Biotronic|||Philips|||Eurocor|||Yinyi Biotech|||Lepu Medical Technology
Frequently Asked Questions
Paclitaxel Drug-Eluting Balloon report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Paclitaxel Drug-Eluting Balloon report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Paclitaxel Drug-Eluting Balloon report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports